Treatment Optimisation for Blood Pressure With Single-Pill Combinations in India

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1981 participants.

Also called NCT05683301

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose other
Phase
Phase 4
Enrolled
  • 1,981 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05683301
Other papers using this trial's data
  • Comparison of dual therapies for hypertension treatment in India: a randomized clinical trial Nature medicine, 2025-09 DOI, PubMed 40715816, PMC12443627 In the PMC Open Access subset under CC BY-NC-ND.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
India (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05683301. Randomized; quadruple masking; primary purpose other. Start 2022-08-30 (actual); primary completion 2024-08-30 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Treatment Optimisation for Blood Pressure With Single-Pill Combinations in India
Acronym
TOPSPIN
Condition
Primary Hypertension
Intervention (Drug)
Amlodipine + Perindopril
Intervention (Drug)
Perindopril + Indapamide
Intervention (Drug)
Amlodipine + Indapamide
Lead sponsor
Centre for Chronic Disease Control, India (class: other)
Collaborator
All India Institute of Medical Sciences (class: other)
Collaborator
Imperial College London (class: other)

Record details

Record id
cardio:ct-nct05683301
Content hash
b422c1552543afaf7b5c127a5a5c9737b267d68354d727598a407364709eadfd